Key result
Case reports outline bleeding risks and elevated PT management during oral anticoagulant therapy.
Why the study?
The risk-benefit ratio of oral anticoagulant therapy requires careful evaluation due to expanding indications and the major complication of bleeding.
Case Report
A careful review of all aspects of therapy with patients new to oral anticoagulants may improve compliance and lessen the incidence of bleeding.
May warrant pre-therapy reviews to reduce bleeding with expanding anticoagulant use; leaves open optimal strategies for contemporary agents.
Preview The risk-benefit ratio of oral anticoagulant therapy is of special concern in the 1990s, because potential uses of these agents are expanding rapidly. A careful review of all aspects of therapy with patients new to anticoagulants may improve compliance and lessen the incidence of bleeding, the major complication. Dr Brigden provides case reports to illustrate risk factors for bleeding, approaches to determining the source, and management of elevated prothrombin time.
No takes yet. Share an insight, caveat, or question.
Malcolm L. Brigden (1995) conducted a case report in Bleeding complications of oral anticoagulant therapy. Oral anticoagulant therapy was evaluated. Case reports illustrate risk factors for bleeding, approaches to determining the source, and management of elevated prothrombin time in patients on oral anticoagulant therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: